Linda Baddour

Ms. Baddour has over twenty years of experience in the Life Sciences industry. From June 2007 to October 2018, Ms. Baddour served as Executive Vice President and CFO of PRA Health Sciences (PRA).
PRA is a global contract research organization and data science company serving the pharmaceutical and biotech industry for more than 40 years. PRA, formerly a Genstar portfolio company, grew from approximately 3 000 employees to over 17,000 during her tenure with the company.
In addition to her eleven years at PRA, Ms. Baddour worked at Pharmaceutical Product Development, Inc (PPD) from November 1995 to May 2007. She served as CFO at PPD from 2002 un l her departure to join PRA. At PPD, she also managed the company’s M&A and information technology strategies. Prior to being named CFO at PPD, she was Treasurer and Chief Accounting Officer.
Ms. Baddour serves on Genstar’s Strategic Advisory Board and advises the firm in the area of healthcare. She is also currently serving on the board of directors of Flourish Research, Signant Health, Waters Corporation (Waters) and Cyroport.
Waters Is one of the world’s leading specialty measurement companies focused on improving human health and well-being through the application of advanced analytical science technologies. Cyroport provides full-scale supply chain management for the life science industry.
Ms. Baddour is also a certified public accountant.
EDUCATION
University of North Carolina at Wilmington, MBA
University of North Carolina at Wilmington, BS Accounting